Trump announces Medicare will cover GLP-1 drugs for weight loss starting July 1

President Trump stated Medicare will begin covering GLP-1 medications for weight loss starting July 1, 2026. This represents a major policy shift, as Medicare currently covers these drugs only for Type 2 diabetes, not for obesity alone. If implemented via CMS rulemaking, it would open coverage to millions of Medicare beneficiaries and require updates to Part D plan formularies. Practices should prepare for a surge in patient inquiries and potential prior authorization requirements for this new indication. Verify the final CMS guidance and any associated National Coverage Determination before July 1 to confirm the exact coverage criteria and billing rules.